NIDCR Clinical Trial Planning Grant (R34)

Post Date

July 9th 2008

Application Due Date

September 7th 2011

Funding Opportunity Number

PAR-08-195

CFDA Number(s)

93.121

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Funding

• Award Range:

  $None - $None

Grant Description

-Purpose. This FOA, issued by the National Institute of Dental and Craniofacial Research (NIDCR), National Institutes of Health, will support clinical trial planning (R34) grants for the comprehensive planning, design and documentation of investigator-initiated Phase I, II, III, or IV interventional clinical trials.ÊInterventional behavioral studies, sometimes referred to as Stage I, II, III or IV studies, are included. The R34 planning grant is designed to:Ê(1) permit early peer review of the rationale for the proposed clinical trial; (2) permit early assessment of the design and implementation plans of the proposed trial; and (3) provide support for the development of a comprehensive clinical trial protocol and associated documents including a Manual of Procedures. The complete protocol and associated documents are required components of any subsequent clinical trial implementation (U01) application. The product of the R34 will be either an application for a clinical trial implementation cooperative agreement (U01) or a report summarizing the work completed and the reasons for not proceeding to a clinical trial implementation application. Pre-approval from the NIDCR is required for the submission of the R34 application. -Mechanism of Support. This FOA will utilize the NIDCR Clinical Trial Planning (R34) grant mechanism. -Funds Available and Anticipated Number of Awards.ÊAwards issued under this FOA are contingent upon the availability of funds and the submission of meritorious applications.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/pa-files/PAR-08-195.html